Where does Neuronetics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neuronetics, Inc. ranks #9,331 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neuronetics, Inc. hold?

Neuronetics, Inc. holds 34 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Neuronetics, Inc.'s Innovation Score?

Neuronetics, Inc. has an Innovation Score of 37.1 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Neuronetics, Inc. focus on?

Neuronetics, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 17 patents, ranking #211 of 1,943 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Neuronetics, Inc.'s patent grant rate increasing or decreasing?

Neuronetics, Inc.'s recent grant velocity is -12% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Neuronetics, Inc.'s patents?

Neuronetics, Inc.'s patents average 19.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neuronetics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Neuronetics, Inc.

USPTO PatentsView assignee record - 34 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neuronetics ranks #9,331 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 9 technology areas.

#9,331
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.1/100): 19.5
avg claims per patent: -12%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9331 · US Corporation #9,331 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 34 grants
UPPER-Q #9,331/49,997
PHOTO-FINISH Nauto
CPC-NARROW A61N · 9 areas
INNOV-THIN 37.1/100
CLAIMS-RICH 19.5 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -12% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nauto, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neuronetics’s 37.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.3 pts (33%) Velocity 2.6 pts (7%) Breadth 10.6 pts (28%) Claim depth 11.7 pts (31%)

Qualcomm Incorporated · highest

85
LedEngin · near

37
Moxietec · near

37
Neuronetics · this assignee

37
Springfield · near

37
Miltenyi Biotec · near

37
3D Lighting… · lowest

7

What this shows Neuronetics's Innovation Score is 37.1/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neuronetics?

Each dot is one of Neuronetics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neuronetics’s own 19.5 claims/patent is ABOVE the 15.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neuronetics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neuronetics's grants concentrate

Neuronetics, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 50% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2023. By volume, Neuronetics sits between Niigata University and Oldcastle Precast Inc..

Neuronetics's three-year grant acceleration

Neuronetics, Inc. shows 5 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Niigata University

34
Nippon Steel & Su…

34
NL Giken Incorpor…

34
Nauto

34
Nordex Energy SE…

34
Ohara

34
OLD Dominion Univ…

34
Oldcastle Precast

34
Neuronetics ◀

34

What this shows Neuronetics holds 34 patents at rank #9,337, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neuronetics

By rank, the assignees closest to #9,337 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Neuronetics's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Neuronetics, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Neuronetics ranks #211 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

LedEngin, Inc. 37 Springfield, Inc. 37 Moxietec, LLC 37 Miltenyi Biotec, Inc. 37

Neuronetics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Neuronetics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	5.9%
2016	3	8.8%
2017	3	8.8%
2018	4	11.8%
2019	4	11.8%
2020	5	14.7%
2021	4	11.8%
2022	2	5.9%
2023	1	2.9%
2024	2	5.9%
2025partial year	4	11.8%

Which technologies does Neuronetics, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 17

A61B - DIAGNOSIS; SURGERY; Identification 12

G06V - Image OR Video Recognition OR Understanding 6

G06T - Image Data Processing OR Generation, IN General 6

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 6

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 4

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 3

F28D - Heat-exchange Apparatus, NOT Provided FOR IN Another Subclass, IN Which THE Heat-exchange Media DO NOT Come Into Direct Contact 2

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Neuronetics, Inc.'s patent record in context - here's where to go next.

Neuronetics, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 50% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #9,331 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neuronetics, Inc. against Niigata University, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.